- Report
- August 2025
- 198 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- October 2025
- 150 Pages
Germany
From €3435EUR$3,850USD£3,029GBP
- Book
- November 2019
United States
- Book
- November 2023
Global
€1525EUR$1,831USD£1,392GBP
€1890EUR$2,269USD£1,725GBP

Vertebrate biotechnology is a rapidly growing field of research and development that focuses on the use of vertebrate animals for the production of biopharmaceuticals, medical devices, and other products. It involves the use of genetic engineering, cell culture, and tissue engineering to create new products and therapies. Vertebrate biotechnology has the potential to revolutionize the way we treat diseases and improve the quality of life for millions of people.
Vertebrate biotechnology is used in a variety of industries, including pharmaceuticals, medical devices, and animal health. It is also used in research and development of new treatments and therapies for a variety of diseases. Companies in the vertebrate biotechnology market include AbbVie, Amgen, AstraZeneca, Biogen, Celgene, Gilead Sciences, Johnson & Johnson, Merck, Novartis, and Pfizer. Show Less Read more